Diagnostic Electrocardiograph Market Report 2024

The diagnostic electrocardiograph market size has grown strongly in recent years. It will grow from $7.59 billion in 2023 to $8.12 billion in 2024 at a compound annual growth rate (CAGR) of 7%. The growth during the historic period can be attributed to the aging global population, a higher incidence of cardiovascular diseases, rising global healthcare expenditure, increased awareness and screening programs for cardiovascular health, and regulatory support for the early diagnosis and treatment of cardiac conditions.

The diagnostic electrocardiograph market size is expected to see strong growth in the next few years. It will grow to $10.66 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the expansion of healthcare infrastructure in emerging markets, regulatory initiatives, rising awareness and proactive health management among consumers, increasing investments in healthcare, and a growing geriatric population. Major trends in the forecast period include the integration of artificial intelligence (AI), portable and wireless ECG devices, the adoption of telehealth, advancements in wearable ECG technology, and personalized medicine.

The rising global prevalence of heart disorders is anticipated to boost the growth of the diagnostic electrocardiograph market. Heart disorders encompass a variety of conditions affecting the cardiovascular system, such as arrhythmias, heart attacks, congenital defects, and heart failure. The increase in these disorders is due to factors such as aging populations, sedentary lifestyles, and poor dietary habits, which lead to higher rates of obesity and hypertension - significant risk factors for heart conditions. Diagnostic electrocardiography (ECG) is essential for the early detection, monitoring, and management of cardiac conditions by providing non-invasive assessments of the heart's electrical activity. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in cardiovascular deaths to 931,578, a rise of 3,000 from the previous year’s figure of 928,741. Thus, the growing prevalence of heart disorders worldwide will drive the expansion of the diagnostic electrocardiograph market.

Leading companies in the diagnostic electrocardiograph market are focusing on advanced technologies, such as AI-powered ECG systems, to enhance the accuracy and efficiency of diagnosing cardiac conditions. Integrating AI into ECG devices improves diagnostic precision and efficiency in cardiovascular healthcare settings. For example, in June 2024, AliveCor, a US-based medical technology company, launched its KAI 12L AI technology along with the Kardia 12L ECG System. This innovation is the world’s first AI capable of detecting critical cardiac conditions, including heart attacks, with a simplified lead set. The new ECG system, using patented technology, is the world’s first handheld 12-lead ECG system powered by AI, featuring a unique single-cable design.

In July 2023, Inuvi Health Ltd., a UK-based provider of domiciliary health assessments and nationwide phlebotomy services, acquired Express Diagnostics for an undisclosed amount. This acquisition enhances Inuvi's diagnostics business by expanding its capabilities and enabling it to offer a broader range of diagnostic services, thereby reaching a wider client base. Express Diagnostics, based in the UK, specializes in developing and manufacturing diagnostic testing solutions, including electrocardiographs.

Major companies operating in the diagnostic electrocardiograph market are Koninklijke Philips N.V., GE Healthcare Inc., Suzuken Company Limited, Mindray Medical International Limited, Nihon Kohden Corporation, OSI Systems Inc., Fukuda Denshi Co. Ltd., Midmark Corporation, BTL Group of Companies, BioTelemetry Inc., Spacelabs Healthcare Inc., Welch Allyn Inc., Schiller AG, CardioNet Inc., VectraCor Inc., BPL Limited, SunTech Medical Inc., Mortara Instrument Inc., Allengers Medical Systems Limited, Bionet Co. Ltd., ScottCare Corporation, Nasiff Associates Inc., Compumed Inc., Norav Medical, Nexus Lifecare Pvt. Ltd.

North America was the largest region in the diagnostic electrocardiograph market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic electrocardiograph market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic electrocardiograph market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A diagnostic electrocardiograph (ECG or EKG) is a medical device designed to record the electrical activity of the heart over a period of time. This device captures the electrical impulses produced by cardiac muscle depolarization, which are then converted into a visual representation (electrocardiogram) displayed either on paper or digitally on a screen. Diagnostic ECGs are crucial tools in cardiology for evaluating heart health, diagnosing various heart conditions such as arrhythmias, ischemia, and myocardial infarction (heart attacks), and monitoring the effectiveness of treatments.

The primary product and service types in diagnostic electrocardiography include resting electrocardiogram (ECG), stress electrocardiogram (ECG) devices, Holter monitors, implantable loop recorders, event monitors, mobile cardiac telemetry (MCT) devices, and smart electrocardiogram (ECG) monitors. Resting ECG devices record the heart's electrical activity while the patient is at rest, helping to detect abnormalities in heart rhythms, heart attacks, and other cardiac conditions. The lead types include 12 leads, 5 leads, and 3 leads, among others. These devices are used in hospitals, clinics, cardiac centers, ambulatory surgical centers, and other healthcare settings.

The diagnostic electrocardiograph market research report is one of a series of new reports that provides diagnostic electrocardiograph market statistics, including diagnostic electrocardiograph industry global market size, regional shares, competitors with an diagnostic electrocardiograph market share, detailed diagnostic electrocardiograph market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic electrocardiograph industry. This diagnostic electrocardiograph market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic electrocardiograph market consists of revenues earned by entities providing services such as installation, maintenance, calibration, training, and consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic electrocardiograph market also includes sales of ECG electrodes, software for ECG analysis, telemetry systems, ambulatory ECG systems, ECG cables, and leads. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.